Dr Ian Mann

• 18 years of experience
• Consultant cardiologist & electrophysiologist - OneWelbeck (present)
• Consultant cardiologist & electrophysiologist - Nuffield Helath Haywards (present)
• Drug Development Physician Weatherden (present) 
• Consultant cardiologist & electrophysiologist - Royal Sussex County Hospital, Brighton (present)
• Chief Medical Officer - Hometest (2021 - 2022) 

• Endo-epicardial AF ablation, utilizing the pericardial CO2 insufflation to achieve linear radiofrequency lesion sets for persistent AF. Heart Rhythm 2022 May 19(5):S141-S142. DOI: 10.1016/jrhtn.2022.02.856
• RETRO-Mapping: A new approach to activation mapping in persistent AF reveals evidence of spatiotemporal stability. Circ AE. 2021 June;14(6):3009602
• Cycle length evaluation in persistent atrial fibrillation using kernel density estimation to identify transient and stable rapid atrial activation. Cardiovasc Eng Technol. 2021 Aug
• A new era in epicardial access for the ablation of ventricular arrhythmias: The epi-CO2 registry. JACC Clin Electrophysiol. 2021 Jan;7(1):85-96. DOI: 10.1016/j.jacep.2020.07.027
• Evaluation of a new algorithm for tracking activation during atrial fibrillation using multipolarr catheters in humans. Journal of Cardiovascular Electrophysiology. 2019;1-11. DOI: 10.1111/jce.14033

• British Heart Foundation Clinical Research Training Fellowship

Dr Ian Mann is a leading consultant cardiologist and electrophysiologist with over 15 years' experience based in London and Sussex. He has a specialist interest in atrial fibrillation, and also specialises in several different aspects of cardiology, including palpitations, dizzy episodes, loss of consciousness, chest pain, hypertension, heart failure, valve disease, and general cardiology. He is also a specialist in the management and ablation for SVT (supraventricular tachycardia), atrial tachycardia/flutter, ventricular tachycardia/ectopy and implants simple and complex permanent pacemakers and defibrillators.

Dr Mann completed his PhD at Imperial College London, involving research into novel methods to map atrial fibrillation, with the aim of improving ablation techniques and procedure outcomes. He continues his research interests in atrial fibrillation at the Royal Sussex County Hospital, supervising academic research fellows to undertake research towards their PhD. Dr Mann has led clinical trials, and collaborates with other research groups both nationally and internationally. His research has been published in well recognised international journals. He is a high volume procedural operator, having undertaken well over 500 ablation procedures for atrial fibrillation alone.